Follow
Erel Joffe MD MSc
Title
Cited by
Cited by
Year
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
Y Herishanu, I Avivi, A Aharon, G Shefer, S Levi, Y Bronstein, M Morales, ...
Blood, The Journal of the American Society of Hematology 137 (23), 3165-3173, 2021
6042021
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups
CL Batlevi, F Sha, A Alperovich, A Ni, K Smith, Z Ying, JD Soumerai, ...
Blood cancer journal 10 (7), 74, 2020
1222020
Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
AJ Moskowitz, G Shah, H Schöder, N Ganesan, E Drill, H Hancock, ...
Journal of clinical oncology 39 (28), 3109, 2021
1182021
Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
R Stuver, GL Shah, NS Korde, LE Roeker, AR Mato, CL Batlevi, DJ Chung, ...
Cancer Cell 40 (6), 590-591, 2022
812022
Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
D Sermer, C Batlevi, ML Palomba, G Shah, RJ Lin, MA Perales, M Scordo, ...
Blood advances 4 (19), 4669-4678, 2020
812020
Evaluation of a problem-specific SBAR tool to improve after-hours nurse-physician phone communication: a randomized trial
E Joffe, JP Turley, KO Hwang, TR Johnson, CW Johnson, EV Bernstam
The Joint Commission Journal on Quality and Patient Safety 39 (11), 495-AP6, 2013
702013
Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small …
JD Soumerai, AR Mato, A Dogan, VE Seshan, E Joffe, K Flaherty, J Carter, ...
The Lancet Haematology 8 (12), e879-e890, 2021
672021
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
S Borchmann, E Joffe, CH Moskowitz, AD Zelenetz, A Noy, CS Portlock, ...
Blood, The Journal of the American Society of Hematology 133 (20), 2121-2129, 2019
532019
Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
S Bobillo, E Joffe, D Sermer, P Mondello, P Ghione, PC Caron, ...
Blood cancer journal 11 (6), 113, 2021
452021
Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era
S Bobillo, E Joffe, JA Lavery, D Sermer, P Ghione, A Noy, PC Caron, ...
Blood, The Journal of the American Society of Hematology 137 (1), 39-48, 2021
432021
The value of electrophysiologic study in decision-making regarding the need for pacemaker implantation after TAVI
O Tovia-Brodie, Y Ben-Haim, E Joffe, A Finkelstein, A Glick, R Rosso, ...
Journal of Interventional Cardiac Electrophysiology 48, 121-130, 2017
432017
A benchmark comparison of deterministic and probabilistic methods for defining manual review datasets in duplicate records reconciliation
E Joffe, MJ Byrne, P Reeder, JR Herskovic, CW Johnson, AB McCoy, ...
Journal of the American Medical Informatics Association 21 (1), 97-104, 2014
392014
The value of PET/CT in detecting bone marrow involvement in patients with follicular lymphoma
C Perry, H Lerman, E Joffe, N Sarid, O Amit, I Avivi, M Kesler, J Ben-Ezra, ...
Medicine 95 (9), e2910, 2016
362016
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay
AM Intlekofer, E Joffe, CL Batlevi, P Hilden, J He, VE Seshan, AD Zelenetz, ...
Blood cancer journal 8 (6), 60, 2018
322018
C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia
D Justo, S Lachmi, N Saar, E Joffe, L Atzmony, N Mashav, O Henis, ...
European journal of internal medicine 20 (5), 518-521, 2009
312009
C-reactive protein to distinguish pneumonia from acute decompensated heart failure
E Joffe, D Justo, N Mashav, M Swartzon, H Gur, S Berliner, Y Paran
Clinical biochemistry 42 (16-17), 1628-1634, 2009
302009
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
M Lumish, L Falchi, BS Imber, M Scordo, G von Keudell, E Joffe
Journal of Hematology & Oncology 14, 1-19, 2021
252021
Duplicate patient records–implication for missed laboratory results
E Joffe, CF Bearden, MJ Byrne, EV Bernstam
AMIA annual symposium proceedings 2012, 1269, 2012
252012
Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma
CL Batlevi, F Sha, A Alperovich, A Ni, K Smith, Z Ying, JF Gerecitano, ...
European Journal of Cancer 126, 78-90, 2020
242020
Nanatinostat (Nstat) and Valganciclovir (VGCV) in relapsed/refractory (R/R) Epstein-Barr virus-positive (EBV+) lymphomas: final results from the phase 1b/2 VT3996-201 study
BM Haverkos, O Alpdogan, R Baiocchi, JE Brammer, TA Feldman, ...
Blood 138, 623, 2021
222021
The system can't perform the operation now. Try again later.
Articles 1–20